Dear Editor, Tuberculosis (TB) is a formidable challenge to global health and is caused by an ancient pathogen, Mycobacterium tuberculosis (WHO, 2010) . In the pre-antibiotic era, TB killed 20% of adults in Europe and North America in the period from the seventeenth to the nineteenth centuries (Wilson, 2005) . Since antibiotics have been included in TB treatment regimens, millions of human lives have been saved by this chemotherapy. However, the standard anti-tuberculosis therapy is only effective for drug-susceptible TB but not for multi-drug resistant and extensively drug-resistant TB. Unfortunately, our knowledge of drug resistance in mycobacteria remains unclear and thus hampers the development of new antitubercular drugs. The basic mechanisms of drug resistance in mycobacteria are complicated and the outcome of drug resistance stems from evolution in the final analysis. Understanding the evolutionary strategies used by M. tuberculosis might give new insights into designing control strategies against M. tuberculosis (Little et al,. 2012) .
As the most successful bacterial pathogen, M. tuberculosis has evolved elegant strategies to evade a host's immune defensive system. For example, D'Arcy Hart and colleagues observed that M. tuberculosis-containing phagosomes do not fuse with the lysosome inside murine macrophages (Armstrong and Hart, 1971) . Several studies indicated that M. tuberculosis succeeds as an intracellular pathogen is partially due to its ability to survive and persist inside macrophages, which provide hostile environments with starvation and other stresses (Podinovskaia et al., 2013) . When M. tuberculosis infects macrophages, the mycobacteria must overcome exogenous reactive oxygen species (ROS), one of the classical innate defense mechanisms against infection. Additionally, during latency, M. tuberculosis continues to be under oxidative stress; thus, the accumulation of mutations caused by oxidative DNA damage was predicted to be a potential risk for drug resistance (Ford et al., 2011) . Recently, studies have shown a correlation of ROS damage of DNA with antibiotic resistance (Kohanski et al., 2010) , although this notion has been disputed by other recent studies that argued that antibiotic exposure did not induce the formation of ROS (Keren et al., 2013) . The role of ROS in the evolution of drug resistance is still an open question.
Currently, the view of evolution is mostly derived from genomic sequencing and lacks direct experimental evidence. In this study, to explore the correlation between hydrogen peroxide (H 2 O 2 ) resistance and growth benefits in mycobacteria under stress, we developed a model for evolutionary screening of H 2 O 2 -resistant mutations in a pathogenic mycobacteria model, M. smegmatis, using a clinically important stressor, H 2 O 2 (Fig. 1 (Table S2 ). The data showed that G:C > T:A transversion and G:C > A:T transition were the major mutation types (Fig. 2E) . The ratio of G:C > T:A transversion to G:C > A:T transition is an index to measure the contribution of oxidative DNA damage to the development of antibiotic resistance; it was 0.7 in mc 2 51 but is 0.25 under normal growth conditions. This increased ratio indicated that oxidative DNA damage caused the DNA mutations of mc 2 51.
It should be noted that the ratio for mutations of M. tuberculosis isolated from macaques with latent infection increased drastically to 0.67 (Ford et al., 2011) , indicating that oxidative DNA damage is a dominant source of mutation during both active and latent phases of M. tuberculosis. To further determine the possible roles of those genes in H 2 O 2 resistance, the sequences of the corresponding genes amplified from wild type mc 2 155 genomic DNA were cloned into the integrating vector pMV361 (Table S4) (Fig. 2F) , and KatG was confirmed by mass spectrometry analysis (Fig. 2F) .
As an intracellular pathogen, the success of M. tuberculosis is partially due to its ability to survive and persist in macrophages. For example, ROS produced by the host is one of the most important classical innate defense mechanisms against infection. To defend against ROS stress, mycobacteria have evolved many detoxification strategies to scavenge H 2 O 2 (Kumar et al., 2011 (Table S3) . Furthermore, the mass spectrometry results indicated that the mutation of fur changed the expression of katG, causing high resistance to H 2 O 2 . Our Growth fitness acquired with H 2 O 2 adaptation in mycobacteria LETTER results showed that the development of H 2 O 2 resistance in mycobacteria led to the gain of growth benefits in starvation conditions and within macrophages.
The ratio of G:C > T:A transversion to G:C > A:T transition mutation is used as an index to measure the contribution of oxidative DNA damage to the development of antibiotic resistance (Hershberg et al., 2008) . If the oxidative DNA damage contributes to DNA mutation, this ratio will increase significantly. In this study, we calculated the ratio as 0.78, which indicated that oxidative DNA damage is a dominant source of mutation for mycobacteria (Fig. 2E) . A similar ratio (0.67) was also reported in mutations of M. tuberculosis isolated from macaques with latent infection (Ford et al., 2011) . Additionally, previous studies have shown that the ratio of G:C > T:A transversion to G:C > A:T transition that confers resistance to anti-TB drugs is 0.71 (Wang et al., 2013) , which is similar to our results (0.78). However, in our study, the MICs of various antibiotics did not differ between wild type mc 2 155 and mc 2 51 except that of INH, a prodrug that needs bacterial ROS activation. The results suggested that the mutation ratio is an effect rather than a cause for the acquisition of antibiotic resistance.
As ROS is correlated with M. tuberculosis pathogenesis, we explored whether mycobacteria obtain any benefits when evolving to adjust their resistance to H 2 O 2 . Our results showed that endogenous H 2 O 2 resistance confers bacterial growth advantages. Newly identified genes, such as carD, moaD1, and pp54, involved in oxidative stress, have been shown to be 155 and the identification of KatG using mass spectrometry. Whole lysates including approximately 50 μg protein were separated by nondenaturing 7.4% polyacrylamide gels. By searching the M. smegmatis protein database, an MS/MS spectrum matched GPDTITSGLEVVWTNTPTK. The highlighted peak is specific to the sequence of KatG. The underlined peptides were identified by MS/MS searching of the band covering 68% of the KatG sequence.
